SCHEMBL17129449

SCHEMBL17129449

CC(C)c1ccc(COc2ccc(B3OC(C)(C)C(C)(C)O3)c(Cl)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.43
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
MAOA P21397 1/20 0.43
ACHE P22303 1/20 0.43
HRH3 Q9Y5N1 1/20 0.41
AR P10275 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.38
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 1/20 0.38
DGAT1 O75907 1/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
SPHK1 Q9NYA1 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.38
IDO1 P14902 2/20 0.37
GCGR P47871 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17128957 0.87 AR (0.43) MAOBRXRARXRBMAOAACHE
SCHEMBL17129015 0.86 MAOA (0.42) MAOBRXRARXRBMAOAACHE
SCHEMBL17128924 0.84 MAOB (0.43) MAOBRXRARXRBMAOAACHE
SCHEMBL21234415 0.81 DGAT1 (0.53) RXRARXRBHRH3L3MBTL1ALDH1A1
SCHEMBL17128914 0.81 DGAT1 (0.53) RXRARXRBHRH3L3MBTL1ALDH1A1
SCHEMBL1802338 0.77 DGAT1 (0.49) MAOBMAOAHRH3DGAT1
SCHEMBL17129061 0.77 IDO1 (0.38) MAOBRXRARXRBMAOAACHE
SCHEMBL17129524 0.77 RXRA (0.41) MAOBRXRARXRBMAOAACHE
SCHEMBL17129012 0.76 AAK1 (0.49) RXRARXRBDGAT1NPC1RAB9A
SCHEMBL17129250 0.75 GCGR (0.41) MAOBRXRARXRBMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10280170-B2 Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors JANSSEN PHARMACEUTICA NV (BE) 2019-05-07 US disclosed
US-20170174690-A1 SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-06-22 US disclosed
US-20170174690-A1 SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-06-22 US disclosed
WO-2015144799-A1 SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2015-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10280170-B2 Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors ROS1, NOX1, NOX5 MAOB 1222/4885RXRA 2981/4885RXRB 3067/4885
US-20170174690-A1 SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS ROS1, NOX1, NOX5 MAOB 1222/4885RXRA 2981/4885RXRB 3067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.